Form 4: Director Exercises 140,000 Corcept Stock Options

Corcept Therapeutics Director G. Leonard Baker Jr. exercised 140,000 stock options, increasing his indirect beneficial ownership.

Summary

• G. Leonard Baker Jr., a Director and 10% owner of Corcept Therapeutics Inc. (CORT), exercised stock options for a total of 140,000 shares of common stock.
• The transactions occurred on January 27, 2026, and were made pursuant to a Rule 10b5-1(c) plan.
• The exercised options had strike prices ranging from $5.86 to $15.15 per share.
• Following these transactions, Baker Jr.'s indirect beneficial ownership through a trust increased by 140,000 shares.
• His total beneficial ownership now includes 1,095,262 shares held by a trust, 3,308,303 shares held by a limited partnership, and 1,046,631 shares held directly.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive signal. The exercise of options by a significant insider, especially a 10% owner, indicates continued alignment with shareholder interests and potential confidence in the company's long-term value, even if it's a pre-planned compensation event.

Positives

• The exercise of stock options by a Director and 10% owner can signal confidence in the company's future prospects, as it increases their direct or indirect equity stake.
• The transactions were executed under a Rule 10b5-1(c) plan, indicating pre-planned activity and potentially reducing concerns about opportunistic timing.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that insider option exercises are a routine part of executive compensation and often reflect a director's long-term commitment to the company. While not a direct market signal, the increase in beneficial ownership by a significant insider like a 10% owner can be viewed positively within the biotechnology and pharmaceutical industry, where long-term vision and insider alignment are often valued.

Related Party Transactions

• The shares acquired are held indirectly by a trust and a limited partnership, where the reporting person has a trustee role or pecuniary interest, which are considered related party holdings.

Stakeholder Impact

• Shareholders: Increased alignment of a significant insider's interests with shareholders due to higher equity ownership.

Key Dates

Recommendation

While the insider's exercise of options and increased beneficial ownership is a positive signal of confidence, it is a routine compensation event rather than a new strategic investment. It reinforces a 'hold' position for investors who are already confident in Corcept Therapeutics' fundamentals, but it does not present new information significant enough to warrant a 'buy' or 'sell' recommendation on its own.

Keywords

Corcept Therapeutics, CORT, SEC Form 4, Insider Trading, Stock Options, Beneficial Ownership, Director Transaction, Rule 10b5-1, Equity Acquisition